And, as in pre-modern medicine, the treatment is always the same, regardless of the nature of the humoral imbalance ... Then there are the Phillips-curve holdovers, for whom a low unemployment rate ...
DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...